Zubrin

RSS

tepoxalin

Withdrawn
This medicine is now withdrawn from use in the European Union.

Overview

The market authorisation for Zubrin has been withdrawn at the request of the marketing-authorisation holder.

This EPAR was last updated on 08/05/2012

Authorisation details

Product details
Name
Zubrin
Agency product number
EMEA/V/C/000057
Active substance
tepoxalin
International non-proprietary name (INN) or common name
tepoxalin
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QM01AE92
Publication details
Marketing-authorisation holder
Intervet International B. V.
Revision
13
Date of issue of marketing authorisation valid throughout the European Union
13/03/2001
Contact address
Wim de Körverstraat 35
5831 AN Boxmeer
The Netherlands

Product information

02/02/2012 Zubrin - EMEA/V/C/000057 - IB/0032

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Musculo-skeletal system

Therapeutic indication

Reduction of inflammation and relief of pain caused by acute and chronic musculoskeletal disorders.

Assessment history

How useful was this page?

Add your rating